1. Immunology/Inflammation
  2. PD-1/PD-L1
  3. Penpulimab

Penpulimab  (Synonyms: 派安普利单抗)

目录号: HY-P99108 纯度: 98.80%
Data Sheet SDS COA 技术支持

Penpulimab 是一种 IgG1PD-1 单克隆抗体,具有抗肿瘤活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

CAS No. : 2350298-92-7

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥1100
In-stock
5 mg ¥2700
In-stock
10 mg ¥4200
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Penpulimab is an IgG1 backbone anti-PD-1 monoclonal antibody with antitumor activities[1].

同型

Human IgG1 kappa

推荐同型对照抗体
种属

Chimeric; Humanized

体外研究
(In Vitro)

Penpulimab demonstrates better stability and a lower level of host-cell protein residue compared with IgG4 backbone anti-PD-1 antibodies[1].
Penpulimab does not mediate complement-dependent cytotoxicity (CDC) or antibody-dependent cell-mediated cytotoxicity (ADCC) and induces no remarkable IL-6 and IL-8 release by activated macrophages[1].
Penpulimab exhibits slower binding off-rate for human PD-1 than Nivolumab (HY-P9903) and Pembrolizumab (HY-P9902)[1].
Penpulimab potentiates T cell activation via PD-1/PD-L1 blockade[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Penpulimab (5 mg/kg; i.p.; twice a week, 3weeks) inhibits tumor growth in mice[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MC38-hPD-L1 tumor-bearing B-hPD-1 humanized mouse model[2]
Dosage: 5 mg/kg
Administration: IP, twice a week, 3weeks
Result: Showed moderate inhibition of tumor growth (tumor volume: 58.4% of control group). Treatment combined with anlotinib (1 mg/kg, every day, p.o) significantly decreased tumor volume to 36.5% of control group.
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT05949931Sun Yat-sen University
Classic Hodgkin Lymphoma
August 2023Phase 2
NCT05485350Peking University Third Hospital
Non-Small Cell Lung Cancer
September 12, 2022Phase 2
NCT05028504Sichuan Cancer Hospital and Research Institute
Gynecological Cancer
May 10, 2022Phase 2
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

派安普利单抗

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

Format
  • Human IgG1 kappa
纯度 & 产品资料

纯度: 98.80%

参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • 抗体抑制剂请问怎么灭菌呢?

    我们的抗体抑制剂产品本身就是无菌的,细胞实验可以用培养基稀释,动物实验可以用无菌 PBS 或者生理盐水稀释。

  • 抗体抑制剂的人源化,人鼠嵌合抗体有什么区别呢?

    人鼠嵌合抗体由鼠源可变区+人源恒定区组成,人源化约65%,免疫原性较高。人源化抗体仅保留鼠源CDR,其余为人源结构,人源化约90%,免疫原性较低。相比嵌合抗体,人源化抗体更接近人体抗体,安全性更高。

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Penpulimab
目录号:
HY-P99108
需求量:
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》